National End Stage Liver Disease Training Program and Treatment Update (ESLD)
|Event Date/Time: Jun 11, 2011||End Date/Time: Jul 09, 2011|
The number of patients with ESLD in the US is expected to continue to grow through 2020, largely due to the burden of chronic viral hepatitis which already exists in our population. As they age, a larger number of patients will develop decompensation events such as variceal bleeding, hepatic encephalopathy, hepatocellular carcinoma, hyponatremia and renal failure. This increase in ESLD patients will create an increasing demand for health care providers who are able to care for the growing population, both in and out of the hospital.
As such, this cutting edge, half-day course will teach diagnosis and management of common complications seen in patients with ESLD. After attending this educational program, the attendee will be able to recognize the treatable complications quickly and use the latest therapies in a reasonable fashion. Learning will concentrate on the areas which are evidence-based or literature-based; including portosystemic encephalopathy, hyponatremia, hepatocellular carcinoma, hepatorenal syndrome and bleeding due to portal hypertension
Conference Highlights Include:
Updates on the latest clinical guidelines with strong patient-focused educational sessions
Local experts providing an interdisciplinary team approach to treatment with physician and midlevel provider faculty
Small classroom learning environment with attendance limited to approximately 50 practitioners per city
Interactive formats including practical case studies, small group discussion, and question and answer opportunities throughout
Receive up to 4.25 AMA PRA Category 1 Creditsâ„¢
Convenient local venues and affordable registration fee
Related midlevel providers and nurse specialists.